Propanc Biopharma approves reverse stock split
- Approved a reverse stock split ratio between 1:2 and 1:10
- Majority Stockholder (50.01% voting equity) approved the split
- Effective date pending Nasdaq approval
PPCB
Propanc Biopharma, Inc. SEC filings
Every EDGAR filing for Propanc Biopharma, Inc. (PPCB), newest first, with AI summaries and stories.
- Ticker
- PPCB
- CIK
- 1517681
- Latest filing
- Oct 8
Next: 10-Q expected ~Nov 16 (deadline Nov 16)
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINEPRE 14CPropanc Biopharma, Inc.PPCBLIVE NOTABLES-1Propanc Biopharma, Inc.PPCBLIVE Propanc Biopharma files S-1
- Filed Form S-1 on 2026-10-05
- Resale of 6,500,000 common shares by selling stockholder
- Series C Preferred Stock convertible into common stock
NOTABLE10-KPropanc Biopharma, Inc.PPCBLIVE ROUTINEEFFECTPropanc Biopharma, Inc.PPCBLIVE NOTABLES-1Propanc Biopharma, Inc.PPCBLIVE ROUTINE8-KPropanc Biopharma, Inc.PPCBLIVE NOTABLE10-QPropanc Biopharma, Inc.PPCBLIVE ROUTINEEFFECTPropanc Biopharma, Inc.PPCBLIVE NOTABLES-1Propanc Biopharma, Inc.PPCBLIVE ROUTINEDEF 14CPropanc Biopharma, Inc.PPCBLIVE ROUTINEPRE 14APropanc Biopharma, Inc.PPCBLIVE ROUTINE424B3Propanc Biopharma, Inc.PPCBLIVE ROUTINE8-KPropanc Biopharma, Inc.PPCBLIVE ROUTINEEFFECTPropanc Biopharma, Inc.PPCBLIVE ROUTINES-1/APropanc Biopharma, Inc.PPCBLIVE NOTABLE10-QPropanc Biopharma, Inc.PPCBLIVE NOTABLES-1Propanc Biopharma, Inc.PPCBLIVE ROUTINE424B3Propanc Biopharma, Inc.PPCBLIVE ROUTINEEFFECTPropanc Biopharma, Inc.PPCBLIVE ROUTINE8-KPropanc Biopharma, Inc.PPCBLIVE ROUTINEDEF 14CPropanc Biopharma, Inc.PPCBLIVE ROUTINEPRE 14CPropanc Biopharma, Inc.PPCBLIVE ROUTINESCHEDULE 13G/APropanc Biopharma, Inc.PPCBLIVE Ownership stake disclosure by Ionic Ventures, LLC (amended)
Ionic Ventures, LLC, filed by
NOTABLE10-QPropanc Biopharma, Inc.PPCBLIVE ROUTINE8-KPropanc Biopharma, Inc.PPCBLIVE